Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Asset Writedowns and Impairment (2019 - 2021)

AVITA Medical filings provide 3 years of Asset Writedowns and Impairment readings, the most recent being $19000.0 for Q3 2021.

  • On a quarterly basis, Asset Writedowns and Impairment rose 124.68% to $19000.0 in Q3 2021 year-over-year; TTM through Dec 2023 was $14000.0, a N/A change, with the full-year FY2023 number at $4000.0, changed N/A from a year prior.
  • Asset Writedowns and Impairment hit $19000.0 in Q3 2021 for AVITA Medical, up from -$5000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $19000.0 in Q3 2021 to a low of -$77000.0 in Q3 2020.
  • Median Asset Writedowns and Impairment over the past 3 years was $8000.0 (2019), compared with a mean of -$8800.0.
  • Biggest five-year swings in Asset Writedowns and Impairment: plummeted 1062.5% in 2020 and later soared 124.68% in 2021.
  • AVITA Medical's Asset Writedowns and Impairment stood at $11000.0 in 2019, then crashed by 145.45% to -$5000.0 in 2020, then soared by 480.0% to $19000.0 in 2021.
  • The last three reported values for Asset Writedowns and Impairment were $19000.0 (Q3 2021), -$5000.0 (Q4 2020), and -$77000.0 (Q3 2020) per Business Quant data.